Your browser doesn't support javascript.
loading
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer.
Campone, M; Bachelot, T; Penault-Llorca, F; Pallis, A; Agrapart, V; Pierrat, M J; Poirot, C; Dubois, F; Xuereb, L; Bossard, C J; Guigal-Stephan, N; Lockhart, B; Andre, F.
Afiliação
  • Campone M; Institut de Cancérologie de l'Ouest-Centre René Gauducheau, Saint-Herblain, France. mario.campone@ico.unicancer.fr.
  • Bachelot T; Centre Léon Bérard Centre de Lutte Contre le Cancer (CLCC) de Lyon, Lyon, France.
  • Penault-Llorca F; Centre Jean Perrin, Clermont-Ferrand, France.
  • Pallis A; Institut de Recherches Internationales Servier, Suresnes, France.
  • Agrapart V; Institut de Recherches Internationales Servier, Suresnes, France.
  • Pierrat MJ; Institut de Recherches Internationales Servier, Suresnes, France.
  • Poirot C; Institut de Recherches Internationales Servier, Suresnes, France.
  • Dubois F; Institut de Recherches Internationales Servier, Suresnes, France.
  • Xuereb L; Institut de Recherches Internationales Servier, Suresnes, France.
  • Bossard CJ; Institut de Recherches Servier, Croissy-sur-Seine, France.
  • Guigal-Stephan N; Institut de Recherches Servier, Croissy-sur-Seine, France.
  • Lockhart B; Institut de Recherches Servier, Croissy-sur-Seine, France.
  • Andre F; Institut Gustave Roussy, Villejuif, France.
Cancer Chemother Pharmacol ; 83(4): 743-753, 2019 04.
Article em En | MEDLINE | ID: mdl-30684019
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrogênio / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrogênio / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2019 Tipo de documento: Article